<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List
href="PREP%20WEB%20ARTICLE%20FOR%20FACT%20SHEET_files/filelist.xml">
<link rel=Preview
href="PREP%20WEB%20ARTICLE%20FOR%20FACT%20SHEET_files/preview.wmf">
<link rel=Edit-Time-Data
href="PREP%20WEB%20ARTICLE%20FOR%20FACT%20SHEET_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>dee</o:Author>
  <o:LastAuthor>Chibwanah Chibwana</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>24</o:TotalTime>
  <o:Created>2023-02-03T08:46:00Z</o:Created>
  <o:LastSaved>2023-02-03T08:46:00Z</o:LastSaved>
  <o:Pages>10</o:Pages>
  <o:Words>1479</o:Words>
  <o:Characters>8434</o:Characters>
  <o:Lines>70</o:Lines>
  <o:Paragraphs>19</o:Paragraphs>
  <o:CharactersWithSpaces>9894</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData
href="PREP%20WEB%20ARTICLE%20FOR%20FACT%20SHEET_files/themedata.thmx">
<link rel=colorSchemeMapping
href="PREP%20WEB%20ARTICLE%20FOR%20FACT%20SHEET_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="371">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:48380857;
	mso-list-type:hybrid;
	mso-list-template-ids:-317028186 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:53746926;
	mso-list-type:hybrid;
	mso-list-template-ids:-1407529742 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:552497519;
	mso-list-type:hybrid;
	mso-list-template-ids:-47052618 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:1322008808;
	mso-list-template-ids:-1503489686;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4
	{mso-list-id:1760298606;
	mso-list-type:hybrid;
	mso-list-template-ids:-1446992832 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5
	{mso-list-id:1900482130;
	mso-list-template-ids:-1502324482;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6
	{mso-list-id:2133938645;
	mso-list-type:hybrid;
	mso-list-template-ids:690887098 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l6:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin-top:0cm;
	mso-para-margin-right:0cm;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
table.MsoTable15Plain5
	{mso-style-name:"Plain Table 5";
	mso-tstyle-rowband-size:1;
	mso-tstyle-colband-size:1;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
table.MsoTable15Plain5FirstRow
	{mso-style-name:"Plain Table 5";
	mso-table-condition:first-row;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-shading:white;
	mso-tstyle-shading-themecolor:background1;
	mso-tstyle-border-bottom:.5pt solid #7F7F7F;
	mso-tstyle-border-bottom-themecolor:text1;
	mso-tstyle-border-bottom-themetint:128;
	font-size:13.0pt;
	mso-ansi-font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-font-style:italic;
	mso-bidi-font-style:italic;}
table.MsoTable15Plain5LastRow
	{mso-style-name:"Plain Table 5";
	mso-table-condition:last-row;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-shading:white;
	mso-tstyle-shading-themecolor:background1;
	mso-tstyle-border-top:.5pt solid #7F7F7F;
	mso-tstyle-border-top-themecolor:text1;
	mso-tstyle-border-top-themetint:128;
	font-size:13.0pt;
	mso-ansi-font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-font-style:italic;
	mso-bidi-font-style:italic;}
table.MsoTable15Plain5FirstCol
	{mso-style-name:"Plain Table 5";
	mso-table-condition:first-column;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-shading:white;
	mso-tstyle-shading-themecolor:background1;
	mso-tstyle-border-right:.5pt solid #7F7F7F;
	mso-tstyle-border-right-themecolor:text1;
	mso-tstyle-border-right-themetint:128;
	text-align:right;
	font-size:13.0pt;
	mso-ansi-font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-font-style:italic;
	mso-bidi-font-style:italic;}
table.MsoTable15Plain5LastCol
	{mso-style-name:"Plain Table 5";
	mso-table-condition:last-column;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-shading:white;
	mso-tstyle-shading-themecolor:background1;
	mso-tstyle-border-left:.5pt solid #7F7F7F;
	mso-tstyle-border-left-themecolor:text1;
	mso-tstyle-border-left-themetint:128;
	font-size:13.0pt;
	mso-ansi-font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-font-style:italic;
	mso-bidi-font-style:italic;}
table.MsoTable15Plain5OddColumn
	{mso-style-name:"Plain Table 5";
	mso-table-condition:odd-column;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-shading:#F2F2F2;
	mso-tstyle-shading-themecolor:background1;
	mso-tstyle-shading-themeshade:242;}
table.MsoTable15Plain5OddRow
	{mso-style-name:"Plain Table 5";
	mso-table-condition:odd-row;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-shading:#F2F2F2;
	mso-tstyle-shading-themecolor:background1;
	mso-tstyle-shading-themeshade:242;}
table.MsoTable15Plain5NECell
	{mso-style-name:"Plain Table 5";
	mso-table-condition:ne-cell;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-border-left:cell-none;}
table.MsoTable15Plain5NWCell
	{mso-style-name:"Plain Table 5";
	mso-table-condition:nw-cell;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-border-right:cell-none;}
table.MsoTable15Plain5SECell
	{mso-style-name:"Plain Table 5";
	mso-table-condition:se-cell;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-border-left:cell-none;}
table.MsoTable15Plain5SWCell
	{mso-style-name:"Plain Table 5";
	mso-table-condition:sw-cell;
	mso-style-priority:45;
	mso-style-unhide:no;
	mso-tstyle-border-right:cell-none;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1028"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-ZW link=blue vlink="#954F72" style='tab-interval:36.0pt'>

<div class=WordSection1>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:14.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:#003300'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_7" o:spid="_x0000_s1027" type="#_x0000_t75"
 style='position:absolute;left:0;text-align:left;margin-left:-70.5pt;
 margin-top:-71.25pt;width:629.25pt;height:373.55pt;z-index:251660288;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:margin;mso-width-percent:0;
 mso-width-relative:margin'>
 <v:imagedata src="PREP%20WEB%20ARTICLE%20FOR%20FACT%20SHEET_files/image001.jpg"
  o:title=""/>
 <w:wrap type="square" anchorx="margin" anchory="margin"/>
</v:shape><![endif]--><![if !vml]><img width=839 height=498
src="PREP%20WEB%20ARTICLE%20FOR%20FACT%20SHEET_files/image002.jpg" align=left
hspace=12 v:shapes="Picture_x0020_7"><![endif]><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:36.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>PRE EXPOSURE PROPHYLAXIS (PREP)<o:p></o:p></span></b></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:14.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:#003300'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN-US style='font-size:
12.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:black;mso-themecolor:text1;background:white'>PrEP is
abbreviated pre-exposure prophylaxis which is a medicine administered to
prevent people from contracting the Human Immunodeficiency Virus (HIV). <o:p></o:p></span></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN-US style='font-size:
12.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:black;mso-themecolor:text1;background:white'>On PrEP
(Pre Exposure Prophylaxis)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt;line-height:150%;
mso-list:l0 level1 lfo4'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1;background:white'>Pre means its taken
before you come into contact with the virus. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l0 level1 lfo4'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1;background:white'>Exposure stands for the
actual contact with the virus. It is contrasted to PEP, which is taken as an
emergency treatment after possible contact with the virus. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt;line-height:150%;
mso-list:l0 level1 lfo4'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1;background:white'>Prophylaxis means measures
taken to prevent the infection before it occurs.<o:p></o:p></span></p>

<p style='line-height:150%;background:white'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:black;mso-themecolor:text1'>The drug works by
preventing HIV from replicating in the body. PrEP acts as a catalyst that helps
the body produce antibodies, which help diseases causing germs and viruses.</span></b><span
lang=EN-US style='font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'> If adhered correctly, PrEP eliminates the
risk of contracting the virus after exposure.<o:p></o:p></span></p>

<p style='line-height:150%;background:white'><span lang=EN-US style='font-family:
"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";color:black;
mso-themecolor:text1'>There are two ways to take it. <b style='mso-bidi-font-weight:
normal'>One tablet per day, for seven days before contact </b>and <b
style='mso-bidi-font-weight:normal'>every day for as long as needed</b>.
Patients can take PrEP on-demand, that is, before having planned sex.<o:p></o:p></span></p>

<p style='line-height:150%;background:white'><span lang=EN-US style='font-family:
"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";color:black;
mso-themecolor:text1'>The most common side effect is dizziness, nausea, and
headache. However, the side effects often clear up after a week.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>PrEP can be pills or shots. There are two
pills approved for use as PrEP: Truvada and Descovy.<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-margin-top-alt:
     auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l5 level1 lfo1;
     tab-stops:list 36.0pt;background:white'><u><span lang=EN-US
     style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>Truvada</span></u><span
     lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>&nbsp;is for people at risk
     through sex or injection drug use<b>.&nbsp;</b><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-margin-top-alt:
     auto;margin-bottom:0cm;margin-bottom:.0001pt;line-height:150%;mso-list:
     l5 level1 lfo1;tab-stops:list 36.0pt;background:white'><u><span
     lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>Descovy </span></u><span
     lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>is for people at risk through
     sex. Descovy is not for people assigned female at birth who are at risk
     for HIV through receptive vaginal sex.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><!--[if gte vml 1]><v:rect id="Rectangle_x0020_1"
 o:spid="_x0000_s1026" style='position:absolute;margin-left:-33.75pt;
 margin-top:-25.5pt;width:501.75pt;height:612pt;z-index:251659264;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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"/><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:relative;
z-index:251659264'><span style='position:absolute;left:-46px;top:-35px;
width:675px;height:822px'>

<table cellpadding=0 cellspacing=0>
 <tr>
  <td width=675 height=822 bgcolor=white style='border:.75pt solid black;
  vertical-align:top;background:white'><![endif]><![if !mso]><span
  style='position:absolute;mso-ignore:vglayout;z-index:251659264'>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div align="center" v:shape="Rectangle_x0020_1" style="margin-left:-50px;margin-right: -50px;"
    class=shape>
    <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:
    .0001pt;text-align:center;line-height:150%;background:white'><b
    style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:18.0pt;
    mso-bidi-font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
    mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>What
    is cabotegravir?<o:p></o:p></span></b></p>
    <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;
    line-height:150%;background:white'><b style='mso-bidi-font-weight:normal'><span
    lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;line-height:
    150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
    color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></b></p>
    <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;
    text-align:justify;line-height:150%;background:white'><span lang=EN-US
    style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
    mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>Cabotegravir
    (CAB-LA) is a prescription medicine approved by the U.S. Food and Drug
    Administration (FDA) and the Medicines Control Authority of Zimbabwe. <o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;
    line-height:150%;background:white'><span lang=EN-US style='font-size:12.0pt;
    line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
    "Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>
    <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:
    .0001pt;text-align:center;line-height:150%;background:white'><b
    style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
    line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
    "Arial Unicode MS";color:black;mso-themecolor:text1'>Cabotegravir oral
    tablet<o:p></o:p></span></b></p>
    <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;
    text-align:justify;line-height:150%;background:white'><span lang=EN-US
    style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
    mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>For
    the short-term treatment of HIV infection in adults and adolescents 12
    years of age and older who weigh at least 35 kg and who meet certain
    requirements, as determined by a health care provider. When used for HIV
    treatment, cabotegravir is always used with the HIV medicine rilpivirine
    (brand name: Edurant).<o:p></o:p></span></p>
    <p class=MsoListParagraph style='margin-bottom:0cm;margin-bottom:.0001pt;
    mso-add-space:auto;text-align:justify;text-indent:-18.0pt;line-height:150%;
    mso-list:l1 level1 lfo6;background:white'><![if !supportLists]><span
    lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:Symbol;
    mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:black;
    mso-themecolor:text1'><span style='mso-list:Ignore'><span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
    line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
    "Arial Unicode MS";color:black;mso-themecolor:text1'>For short-term PrEP to
    reduce the risk of HIV infection in adults and adolescents who weigh at
    least 35 kg.<o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;
    line-height:150%;background:white'><span lang=EN-US style='font-size:12.0pt;
    line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
    "Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>
    <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:
    .0001pt;text-align:center;line-height:150%;background:white'><b
    style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
    line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
    "Arial Unicode MS";color:black;mso-themecolor:text1'>Long-acting injectable
    Cabotegravir<o:p></o:p></span></b></p>
    <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;
    text-align:justify;line-height:150%;background:white'><span lang=EN-US
    style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
    mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>For
    HIV PrEP to reduce the risk of HIV infection in adults and adolescents who
    weigh at least 35 kg.<o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;
    text-align:justify;line-height:150%;background:white'><span lang=EN-US
    style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
    mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;
    text-align:justify;line-height:150%;background:white'><span lang=EN-US
    style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
    mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>CAB-LA
    is an intramuscular injectable, long-acting form of PrEP, with the first 2
    injections administered 4 weeks apart, and followed thereafter by an
    injection every 8 weeks. CAB-LA was shown to be safe and highly effective
    among cisgender women, cisgender men who have sex with men, and transgender
    women who have sex with men in randomized controlled trials. Together,
    these landmark studies found that use of CAB-LA resulted in a 79% relative
    reduction in HIV risk compared with oral PrEP, where adherence to taking
    daily oral medication was often a challenge. Long-acting injectable
    products have also been found to be acceptable and sometimes preferred in
    studies examining community PrEP preferences.<o:p></o:p></span></p>
    <p class=MsoNormal><span lang=EN-US><o:p>&nbsp;</o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  </span><![endif]><![if !mso & !vml]>&nbsp;<![endif]><![if !vml]></td>
 </tr>
</table>

</span></span><![endif]><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
150%;background:white'><span lang=EN-US style='font-size:12.0pt;line-height:
150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN-US style='font-size:
12.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<br style='mso-ignore:vglayout' clear=ALL>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>Difference between PrEP from PEP and ART<o:p></o:p></span></b></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></b></p>

<table class=MsoTable15Plain5 border=0 cellspacing=0 cellpadding=0 width=691
 style='width:518.4pt;border-collapse:collapse;mso-yfti-tbllook:1184;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr style='mso-yfti-irow:-1;mso-yfti-firstrow:yes;mso-yfti-lastfirstrow:yes'>
  <td width=91 valign=top style='width:68.4pt;border:solid black 3.0pt;
  mso-border-themecolor:text1;border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right;line-height:150%;
  mso-yfti-cnfc:517'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>Difference focus<o:p></o:p></span></b></p>
  </td>
  <td width=186 valign=top style='width:139.5pt;border-top:solid black 3.0pt;
  mso-border-top-themecolor:text1;border-left:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;border-right:none;mso-border-left-alt:
  solid black 3.0pt;mso-border-left-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:1'><b
  style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
  mso-bidi-font-size:14.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>PrEP<o:p></o:p></span></b></p>
  </td>
  <td width=204 valign=top style='width:153.0pt;border-top:solid black 3.0pt;
  mso-border-top-themecolor:text1;border-left:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;border-right:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:1'><b
  style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
  mso-bidi-font-size:14.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>PEP<o:p></o:p></span></b></p>
  </td>
  <td width=210 valign=top style='width:157.5pt;border-top:solid black 3.0pt;
  mso-border-top-themecolor:text1;border-left:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;border-right:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:1'><b
  style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
  mso-bidi-font-size:14.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>ARVs<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:0'>
  <td width=91 valign=top style='width:68.4pt;border-top:none;border-left:none;
  border-bottom:solid black 3.0pt;mso-border-bottom-themecolor:text1;
  border-right:solid black 3.0pt;mso-border-right-themecolor:text1;mso-border-top-alt:
  solid black 3.0pt;mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right;line-height:150%;
  mso-yfti-cnfc:68'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>What is its name?<o:p></o:p></span></b></p>
  </td>
  <td width=186 valign=top style='width:139.5pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;mso-border-left-alt:solid black 3.0pt;
  mso-border-left-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>Pre-exposure
  prophylaxis (PrEP)<o:p></o:p></span></p>
  </td>
  <td width=204 valign=top style='width:153.0pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>post-exposure
  prophylaxis (PEP)<o:p></o:p></span></p>
  </td>
  <td width=210 valign=top style='width:157.5pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><strong><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  background:white;font-weight:normal;mso-bidi-font-weight:bold'>Antiretroviral
  drugs (ARVs). </span></strong><span lang=EN-US style='font-size:12.0pt;
  line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
  color:black;mso-themecolor:text1;background:white'>ARV therapy means treating<strong><span
  style='font-family:"Arial",sans-serif;font-weight:normal;mso-bidi-font-weight:
  bold'>&nbsp;viral infections like</span></strong>&nbsp;HIV with drugs.</span><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=91 valign=top style='width:68.4pt;border-top:none;border-left:none;
  border-bottom:solid black 3.0pt;mso-border-bottom-themecolor:text1;
  border-right:solid black 3.0pt;mso-border-right-themecolor:text1;mso-border-top-alt:
  solid black 3.0pt;mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right;line-height:150%;
  mso-yfti-cnfc:4'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>When it is taken?<o:p></o:p></span></b></p>
  </td>
  <td width=186 valign=top style='width:139.5pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;mso-border-left-alt:solid black 3.0pt;
  mso-border-left-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>By
  its name pre- which means before, PrEP is taken every day before possible
  exposure.<o:p></o:p></span></p>
  </td>
  <td width=204 valign=top style='width:153.0pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>By
  its name post- which means after, PEP is taken within 72 hours or 3 days
  after possible exposure to HIV.<o:p></o:p></span></p>
  </td>
  <td width=210 valign=top style='width:157.5pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  background:white'>ARVs refers to<strong><span style='font-family:"Arial",sans-serif;
  font-weight:normal;mso-bidi-font-weight:bold'>&nbsp;taking</span></strong>&nbsp;your
  drugs<strong><span style='font-family:"Arial",sans-serif;font-weight:normal;
  mso-bidi-font-weight:bold'>&nbsp;in the right amounts</span></strong>&nbsp;and<strong><span
  style='font-family:"Arial",sans-serif;font-weight:normal;mso-bidi-font-weight:
  bold'>&nbsp;at the right time. This is called ART adherence</span></strong></span><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=91 valign=top style='width:68.4pt;border:none;border-right:solid black 3.0pt;
  mso-border-right-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right;line-height:150%;
  mso-yfti-cnfc:68'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>Who is it for?<o:p></o:p></span></b></p>
  </td>
  <td width=186 valign=top style='width:139.5pt;border:none;mso-border-top-alt:
  solid black 3.0pt;mso-border-top-themecolor:text1;mso-border-left-alt:solid black 3.0pt;
  mso-border-left-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>PrEP
  is for people who dont have HIV and are at risk of getting HIV from sex and
  drug use.<o:p></o:p></span></p>
  </td>
  <td width=204 valign=top style='width:153.0pt;border:none;mso-border-top-alt:
  solid black 3.0pt;mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>PEP
  is for people who do not have HIV but may have been exposed during sex,
  sharing injection drug equipment, during sexual assault and or at work
  through a needle stick or other injury<o:p></o:p></span></p>
  </td>
  <td width=210 valign=top style='width:157.5pt;border:none;mso-border-top-alt:
  solid black 3.0pt;mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=91 valign=top style='width:68.4pt;border-top:solid windowtext 3.0pt;
  border-left:none;border-bottom:none;border-right:solid black 3.0pt;
  mso-border-right-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right;line-height:150%;
  mso-yfti-cnfc:4'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>How effective is it?<o:p></o:p></span></b></p>
  </td>
  <td width=186 valign=top style='width:139.5pt;border:none;border-top:solid windowtext 3.0pt;
  mso-border-left-alt:solid black 3.0pt;mso-border-left-themecolor:text1;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
  background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
  font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
  color:black;mso-themecolor:text1'>PrEP is highly effective for preventing HIV
  when taken as prescribed.<o:p></o:p></span></p>
  <p class=MsoNormal style='line-height:150%;background:white'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>PrEP
  is less effective when not taken as prescribed. Since PrEP only protects
  against HIV, condom use is still important for the protection against other
  STIs. Condom use is also important to help prevent HIV if PrEP is not taken
  as prescribed.<o:p></o:p></span></p>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=204 valign=top style='width:153.0pt;border:none;border-top:solid windowtext 3.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>&nbsp;PEP
  must be started as soon as possible to be effectiveand always within 72
  hours of a possible exposure.<o:p></o:p></span></p>
  </td>
  <td width=210 valign=top style='width:157.5pt;border:none;border-top:solid windowtext 3.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p style='margin-top:0cm;margin-right:0cm;margin-bottom:10.2pt;margin-left:
  0cm;line-height:150%;background:white'><span lang=EN-US style='font-family:
  "Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";color:black;
  mso-themecolor:text1'>Although ARVs cannot cure someone from HIV, the
  medication, if taken as prescribed, suppresses the replication of the virus. <strong><span
  style='font-family:"Arial",sans-serif;font-weight:normal;mso-bidi-font-weight:
  bold'>ARVs are treatment for HIV with the aim of preventing HIV from
  multiplying in the body</span></strong>. This means that the amount of HIV in
  the body will be reduced, which is termed as 'reducing the viral load.<sup>1</sup><o:p></o:p></span></p>
  <p style='margin-top:0cm;margin-right:0cm;margin-bottom:10.2pt;margin-left:
  0cm;line-height:150%;background:white'><span lang=EN-US style='font-family:
  "Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";color:black;
  mso-themecolor:text1'>When the viral load is low, the CD4 cells can recover
  and your immune system can start fighting off infections again! A low viral
  load also means that there is a lesser chance of spreading the virus to
  others.<sup>1</sup><o:p></o:p></span></p>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=91 valign=top style='width:68.4pt;border:solid black 3.0pt;
  mso-border-themecolor:text1;border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right;line-height:150%;
  mso-yfti-cnfc:68'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>How do you get it?<o:p></o:p></span></b></p>
  </td>
  <td width=186 valign=top style='width:139.5pt;border-top:solid black 3.0pt;
  mso-border-top-themecolor:text1;border-left:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;border-right:none;mso-border-left-alt:
  solid black 3.0pt;mso-border-left-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>Ask
  your health care provider about a prescription for PrEP<o:p></o:p></span></p>
  </td>
  <td width=204 valign=top style='width:153.0pt;border-top:solid black 3.0pt;
  mso-border-top-themecolor:text1;border-left:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;border-right:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>Within
  72 hours of a potential exposure to HIV, talk to your health care provider or
  an emergency room doctor about a prescription for PEP<o:p></o:p></span></p>
  </td>
  <td width=210 valign=top style='width:157.5pt;border-top:solid black 3.0pt;
  mso-border-top-themecolor:text1;border-left:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;border-right:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%;mso-yfti-cnfc:64'><span
  lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>Ask
  your health care provider about a prescription for ARVs<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5;mso-yfti-lastrow:yes'>
  <td width=91 valign=top style='width:68.4pt;border-top:none;border-left:none;
  border-bottom:solid black 3.0pt;mso-border-bottom-themecolor:text1;
  border-right:solid black 3.0pt;mso-border-right-themecolor:text1;mso-border-top-alt:
  solid black 3.0pt;mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right;line-height:150%;
  mso-yfti-cnfc:4'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  mso-bidi-font-style:italic'>When to start taking?<o:p></o:p></span></b></p>
  </td>
  <td width=186 valign=top style='width:139.5pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;mso-border-left-alt:solid black 3.0pt;
  mso-border-left-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  background:white'>As soon as possible if you are on risk. Once you&nbsp;<strong><span
  style='font-family:"Arial",sans-serif;font-weight:normal;mso-bidi-font-weight:
  bold'>start PrEP</span></strong>, you will need to&nbsp;<strong><span
  style='font-family:"Arial",sans-serif;font-weight:normal;mso-bidi-font-weight:
  bold'>take PrEP</span></strong>&nbsp;every day.&nbsp;<strong><span
  style='font-family:"Arial",sans-serif;font-weight:normal;mso-bidi-font-weight:
  bold'>PrEP</span></strong>&nbsp;is much less effective when it is not&nbsp;<strong><span
  style='font-family:"Arial",sans-serif;font-weight:normal;mso-bidi-font-weight:
  bold'>taken</span></strong>&nbsp;every day.</span><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td width=204 valign=top style='width:153.0pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>As
  soon as you are exposed to HIV<o:p></o:p></span></p>
  </td>
  <td width=210 valign=top style='width:157.5pt;border:none;border-bottom:solid black 3.0pt;
  mso-border-bottom-themecolor:text1;mso-border-top-alt:solid black 3.0pt;
  mso-border-top-themecolor:text1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='line-height:150%'><span lang=EN-US
  style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
  mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1;
  background:white'>The short answer is <em><span style='font-family:"Arial",sans-serif'>as
  soon as possible</span></em>. All people regardless of age can take ARVs,
  even pregnant women</span><span lang=EN-US style='font-size:12.0pt;
  line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
  color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:150%'><span lang=EN-US style='font-size:
12.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN-US style='font-size:
12.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>The Need for PrEP<o:p></o:p></span></b></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN-US style='font-size:
12.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:#111111;background:white'>Oral PrEP taken daily during
periods of substantial risk of HIV infection, is a highly-effective prevention
strategy, and can reduce the risk of acquisition of HIV through sexual
intercourse by more than 90%.<span style='mso-spacerun:yes'> </span>The level
of protection provided by oral PrEP does not differ by age, sex, or mode of
acquiring HIV - rectal, penile or vaginal exposure; however, the level of
protection is strongly correlated with adherence. High adherence to oral PrEP
results in a high level of protection from HIV infection whereas suboptimal
adherence does not offer the expected protective benefits.</span><span
lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><u><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p><span style='text-decoration:none'>&nbsp;</span></o:p></span></u></b></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>Identify People at Risk and People at
Substantial Risk for HIV Infection<o:p></o:p></span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;line-height:150%;
     mso-list:l3 level1 lfo2;tab-stops:list 36.0pt'><span lang=EN-US
     style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>Anyone in a sexual
     relationship with someone who has tested HIV-positive<o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;line-height:150%;
     mso-list:l3 level1 lfo2;tab-stops:list 36.0pt'><span lang=EN-US
     style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>Gay or bisexual men who engage
     in anal sex without the use of a condom<o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;line-height:150%;
     mso-list:l3 level1 lfo2;tab-stops:list 36.0pt'><span lang=EN-US
     style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>Gay or bisexual men who have
     been diagnosed with an STI in the past 6 months<o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;line-height:150%;
     mso-list:l3 level1 lfo2;tab-stops:list 36.0pt'><span lang=EN-US
     style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>Straight men and women who do
     not use condoms when engaging in sex with partners who are at a high risk
     of HIV infection<o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;line-height:150%;
     mso-list:l3 level1 lfo2;tab-stops:list 36.0pt'><span lang=EN-US
     style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>Straight men and women who do
     not regularly use condoms while having sex with partners of unknown HIV
     status<o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;line-height:150%;
     mso-list:l3 level1 lfo2;tab-stops:list 36.0pt'><span lang=EN-US
     style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>People who have used injected
     drugs in the last 6 months and shared needles<o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;line-height:150%;
     mso-list:l3 level1 lfo2;tab-stops:list 36.0pt'><span lang=EN-US
     style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
     mso-fareast-font-family:"Arial Unicode MS"'>Anyone who has been in a drug
     treatment program in the past 6 months<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='line-height:150%'><span lang=EN-US style='font-size:
12.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>Identify Key and Vulnerable Populations (KVP)
For PrEP<o:p></o:p></span></b></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN-US style='font-size:
12.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS";color:#212121;background:white'>Oral pre-exposure
prophylaxis (PrEP) is recommended for persons at substantial risk for HIV, including
<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt;line-height:150%;
mso-list:l4 level1 lfo3'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:#212121'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:#212121;background:white'>female sex workers (FSW), <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l4 level1 lfo3'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:#212121'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:#212121;background:white'>men who have sex with men (MSM), <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l4 level1 lfo3'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:#212121'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:#212121;background:white'>people who inject drugs (PWID), and <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l4 level1 lfo3'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:#212121;background:white'>transgender women (TGW)</span><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'> <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt;line-height:150%;
mso-list:l4 level1 lfo3'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>prisoners<o:p></o:p></span></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><u><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p><span style='text-decoration:none'>&nbsp;</span></o:p></span></u></b></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>Explain the relationship between PrEP
effectiveness and Adherence<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black'>PrEP is highly effective for preventing HIV when taken as
prescribed by a health care provider who can be a Nurse or a Doctor. PrEP is
less effective when not taken as prescribed. Since PrEP only protects against
HIV, correct and consistence use of condoms is highly recommended for the
protection against other sexual transmitted infections (STIs). Condom use is
also important to help prevent HIV if PrEP is not taken as prescribed.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black'>Adherence is described in different parts but all in all making up
adherence. Adhering to PrEP is when a PrEP patient take the pills or shots at
the right time and every day. A patient may be expected to meet clinical
attendances as per the health care provider appointment date. Some support
meetings that are hosted at the facility- hospital or clinics or anywhere where
the health care provider plans the meeting to be, are recommended for the PrEP
patient to attend so that they are able to learn much more and share
experiences that they encounter during the period of them taking the medicine.
By that that constitute a well adhering of PrEP.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
style='font-size:14.0pt;mso-bidi-font-size:12.0pt;line-height:150%;font-family:
"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";color:black'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
style='font-size:18.0pt;mso-bidi-font-size:12.0pt;line-height:150%;font-family:
"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";color:black'>Why
We Need PrEP?<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black'>There are several effective HIV prevention interventions already
(e.g. condoms, harm reduction for PWID), we need another prevention
intervention because<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black'><span style='mso-tab-count:1'> </span>New HIV
infections still occur despite prevention efforts<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black'><span style='mso-tab-count:1'> </span>New HIV
infections among priority and key populations are quite high<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><span lang=EN-US style='font-size:12.0pt;line-height:150%;
font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black'>Despite other HIV prevention strategies to prevent HIV infection,
new infections still occur. And high among priority and key populations. PrEP
provides an additional prevention intervention to be used with existing
interventions (such as condoms). It is not meant to replace or be a substitute
for existing interventions.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-bottom-alt:auto;line-height:150%;
background:white'><b style='mso-bidi-font-weight:normal'><span lang=EN-US
style='font-size:18.0pt;mso-bidi-font-size:12.0pt;line-height:150%;font-family:
"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";color:black'>T</span></b><b
style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:18.0pt;
mso-bidi-font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'>he
PrEP regimens as approved in National Guidelines</span></b><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black'><o:p></o:p></span></b></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt;line-height:150%;
mso-list:l2 level1 lfo7'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;line-height:150%;font-family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US><a
href="https://www.ophid.org/treat-all-toolkit/MOHCC%20Guidelines/MOHCC%20Zimbabwe%20OSDM%202017.pdf"><span
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;line-height:150%;font-family:
"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS"'>OPERATIONAL AND
SERVICE DELIVERY MANUAL FOR THE PREVENTION, CARE AND TREATMENT OF HIV IN
ZIMBABWE</span></a></span><span lang=EN-US style='font-size:12.0pt;mso-bidi-font-size:
11.0pt;line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:
"Arial Unicode MS"'> <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt;line-height:150%;
mso-list:l2 level1 lfo7'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US><a
href="12.%09https:/apps.who.int/iris/bitstream/handle/10665/279834/WHO-CDS-HIV-18.10-eng.pdf"><span
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS"'>WHO IMPLEMENTATION TOOL FOR
PRE-EXPOSURE PROPHYLAXIS (PrEP) OF HIV INFECTION</span></a></span><span
lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:16.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:16.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='line-height:150%'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:18.0pt;mso-bidi-font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>References<o:p></o:p></span></b></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt;line-height:150%;
mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US><a
href="https://www.who.int/news/item/28-07-2022-who-recommends-long-acting-cabotegravir-for-hiv-prevention"><span
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS"'>https://www.who.int/news/item/28-07-2022-who-recommends-long-acting-cabotegravir-for-hiv-prevention</span></a></span><span
lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US><a
href="https://clinicalinfo.hiv.gov/en/drugs/cabotegravir-1/patient"><span
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS"'>https://clinicalinfo.hiv.gov/en/drugs/cabotegravir-1/patient</span></a></span><span
lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US><a
href="https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2021/december/20211222_cabotegravir"><span
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS"'>https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2021/december/20211222_cabotegravir</span></a></span><span
lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US><a
href="https://www.prepwatch.org/resources/long-acting-injectable-cabotegravir-for-hiv-prevention-what-do-we-know-and-need-to-know-about-the-risks-and-consequences-of-cabotegravir-resistance/"><span
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS"'>https://www.prepwatch.org/resources/long-acting-injectable-cabotegravir-for-hiv-prevention-what-do-we-know-and-need-to-know-about-the-risks-and-consequences-of-cabotegravir-resistance/</span></a></span><span
lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>&quot;Apretude- cabotegravir kit&quot;.
DailyMed. Retrieved 24 December 2021.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'>Chingono, Nyasha (20 October 2022).
&quot;Zimbabwe becomes first African nation to approve HIV prevention
drug&quot;. The Guardian. Retrieved 21 October 2022.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><span
style='mso-spacerun:yes'></span>&quot;Adopted USANs&quot; (PDF). American
Medical Association. Retrieved 19 September 2014.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><span style='mso-spacerun:yes'></span>World
Health Organization (2015). &quot;International nonproprietary names for
pharmaceutical substances (INN): recommended INN: list 73&quot;. WHO Drug
Information. 29 (1): 701. hdl:10665/331088.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=EN-US style='font-size:12.0pt;
line-height:150%;font-family:"Arial",sans-serif;mso-fareast-font-family:"Arial Unicode MS";
color:black;mso-themecolor:text1'><span style='mso-spacerun:yes'></span>Ryan G
(7 July 2020). &quot;Injectable PrEP Is Even More Effective Than Daily
Truvada&quot;. Poz. Retrieved 9 November 2020.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>10.<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span
lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><span
style='mso-spacerun:yes'></span>Ryan G (9 November 2020). &quot;For Women,
Injectable Cabotegravir Is More Effective Than Truvada as PrEP&quot;. Poz.
Retrieved 9 November 2020.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-family:"Arial",sans-serif;mso-fareast-font-family:Arial'><span
style='mso-list:Ignore'>11.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
lang=EN-US><a
href="https://www.ophid.org/treat-all-toolkit/MOHCC%20Guidelines/MOHCC%20Zimbabwe%20OSDM%202017.pdf"><span
style='font-family:"Arial",sans-serif'>OPERATIONAL AND SERVICE DELIVERY MANUAL
FOR THE PREVENTION, CARE AND TREATMENT OF HIV IN ZIMBABWE</span></a></span><span
lang=EN-US style='font-family:"Arial",sans-serif'> <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:
150%;mso-list:l6 level1 lfo5'><![if !supportLists]><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:Arial;color:black;mso-themecolor:text1'><span
style='mso-list:Ignore'>12.<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span
lang=EN-US><a
href="https://apps.who.int/iris/bitstream/handle/10665/279834/WHO-CDS-HIV-18.10-eng.pdf"><span
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS"'>https://apps.who.int/iris/bitstream/handle/10665/279834/WHO-CDS-HIV-18.10-eng.pdf</span></a></span><span
lang=EN-US style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='line-height:150%'><span lang=EN-US
style='font-size:12.0pt;line-height:150%;font-family:"Arial",sans-serif;
mso-fareast-font-family:"Arial Unicode MS";color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=EN-US><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>
